For women with certain breast cancer risk factors, annual mammograms beginning at age 30 may be beneficial, according to a large-scale study presented Wednesday, Nov. 28 at RSNA 2018.

“The new 2018 Digital Mammography QC Manual will promote uniformity and consistency of QC procedures across the broad spectrum of FDA approved manufacturers,” Eric Berns, PhD, manual author and chair of the ACR Subcommittee on Mammography Quality Assurance, said in a prepared statement.

“This technology can also be valuable to monitor high-risk patients who have increased risk of ovarian and breast cancers due to their genetic mutations,” Quing Zhu, PhD, and lead author of a recent Radiology study said.

Using ultrasound technology, researchers found simple ovarian cysts are not associated with an increased risk of ovarian cancer and do not require additional surveillance or surgical intervention, according to research published Nov. 12 in JAMA Internal Medicine.

Women who receive early and annual breast cancer screenings have lower mortality rates and benefit more from therapy at the time of diagnosis, according to new research published Nov. 8 in the journal Cancer.

A multi-year, Swedish study found three-dimensional (3D) mammography detected over 30 percent more cancers compared to traditional mammography, according to a new 15,000-woman study published in The Lancet Oncology.

On Wednesday, Oct. 10, the Society of Breast Imaging (SBI) and Oxford University Press (OUP) announced a partnership to publish the Journal of Breast Imaging (JBI)—the first peer-reviewed journal dedicated to breast imaging.

Sand Lake Imaging in Orlando, Florida and Shepherd’s Hope, a nonprofit in the area, have partnered to provide free mammograms for uninsured women—their sixth year doing so, according to

Many breast cancer patients opt for mastectomy believing they won’t require future imaging or biopsy. New research published in the Annals of Surgical Oncology found that is not always the case.

Synthetic mammogram paired with digital breast tomosynthesis (DBT) achieved similar sensitivity and specificity as full-field digital mammography (FFDM) in identifying microcalcifications during breast screening, according to an Oct. 2 study in Radiology.

Diffusion-weighted imaging (DWI) could help differentiate between benign and malignant tumors and predict tumor recurrence in breast cancer patients, according to research published Oct. 4 in Academic Radiology. The authors noted that DWI may also serve as a beneficial supplement to contrast-enhanced breast MRI.

Researchers found undergoing MRI scans every six months better detected early breast cancer in young women with a high genetic risk for the disease compared to mammograms.